Developing the testbed

Healthcare and industry have joined forces

All Swedish university hospitals, Regional Cancer Centers and six specialist companies.

University hospitals

A platform for collaboration

The testbed will not form a new healthcare organisation, but rather a platform for collaboration – between the university hospitals and between healthcare and industry. The operation is to be self-supporting.

Much of the work that will be conducted in the testbed is already done today, but there is a lack of coordination between the regions. The idea is to avoid duplication of work and to develop faster. It saves time and resources – and makes the system more flexible. This is an opportunity to share both workload and results. The focus is on projects of national or international interest, not on outcompeting local collaborations.

Scientific projects

A test environment developed by the users

The test environment's technical base is built by clinicians, researchers and companies in concrete research and development collaborations.

Via the research-driven projects, the collaboration model itself – how the country's seven university hospitals conduct coordinated tests in a clinical environment together with innovators – is developed. Other hospitals are also participating.

The users, i.e. the clinical personnel, are key to the testbed's innovative logic Naturally, the professional categories that will be part of the future test environment are also participating in the development work. The Swedish Testbed for Innovative Radiotherapy is also producing methods of actively involving the patients when new solutions are developed.

The consortium

Joint investment by healthcare and industry

The healthcare sector and industry have come together in a consortium to establish the highly specialised testbed. In 2015, the development project will become an established operation.

Partners in the consortium: All Swedish university hospitals, six specialist companies and regional cancer centres.

The investment is being co-financed by VINNOVA and is coordinated by the Innovation Centre at Karolinska University Hospital